13910-48-0

Basic information

• Product Name: 3-(Benzylamino)propylamine
• Synonyms: 3-(Benzylamino)propylamine;AKOS B035593;RARECHEM AL BW 1105;N1-BENZYLPROPANE-1,3-DIAMINE;N-benzylpropane-1,3-diamine;N-Benzyl-1,3-propanediamine;N1-Benzyl-1,3-propanediamine;N-(3-aminopropyl)-N-benzylamine
• CAS NO: 13910-48-0
• Molecular Formula: C₁₀H₁₆N₂
• Molecular Weight: 164.25
• EINECS: 237-680-5
• Product Categories: Polyamines
• Mol File: 13910-48-0.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 102°C/1mmHg(lit.)
• Flash Point: 138.5 ºC
• Appearance: Pale yellow/Liquid
• Density: 0.979 g/cm³
• Vapor Pressure: 0.00548mmHg at 25°C
• Refractive Index: 1.5320
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 9.97±0.10(Predicted)
• CAS DataBase Reference: 3-(Benzylamino)propylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(Benzylamino)propylamine(13910-48-0)
• EPA Substance Registry System: 3-(Benzylamino)propylamine(13910-48-0)

Safety Data

• Hazard Codes: Xi
• RIDADR: UN 2735 8/PG III
• HazardClass: IRRITANT
• PackingGroup: III
• Hazardous Substances Data: 13910-48-0(Hazardous Substances Data)

Usage

General Description

3-(Benzylamino)propylamine is a chemical compound that consists of a propylamine molecule with a benzylamino substituent attached to the second carbon atom. It is also known as N-benzylpropylamine, and it is commonly used as an intermediate for the synthesis of various pharmaceuticals and organic compounds. 3-(Benzylamino)propylamine is a colorless liquid with a faint odor, and it is soluble in water and organic solvents. It is a primary amine, which means it contains an amino group attached to a primary carbon atom. Its chemical structure makes it useful in the production of drugs and other organic compounds, and it is commonly used in the pharmaceutical industry for this purpose.

InChI:InChI=1/C10H16N2/c11-7-4-8-12-9-10-5-2-1-3-6-10/h1-3,5-6,12H,4,7-9,11H2

Upstream product

• 100-44-7 benzyl chloride 
• 109-76-2 Trimethylenediamine 
• 100-52-7 benzaldehyde 
• 107-15-3 ethylenediamine 
• 117654-79-2 1,14-bis(phenylmethyl)-1,5,10,14-tetraazatetradecane tetrahydrochloride 
• 1111644-29-1 N-(3-benzylaminopropyl)-N'-(3-ethylaminopropyl)butane-1,4-diamine 
• 1111643-89-0 N⁽¹⁾-benzyl-N⁽¹⁾,N⁽³⁾-bis(2-nitrobenzenesulfonyl)propane-1,3-diamine 
• 100-46-9 benzylamine 
• 87142-90-3 N¹-[1-Phenyl-meth-(E)-ylidene]-propane-1,3-diamine 
• 103-67-3 benzyl-methyl-amine 
• 42245-33-0 N-benzyl-3-chloropropylamine 
• 107-13-1 acrylonitrile 
• 706-03-6 3-(benzylamino)propionitrile 

Downstream Products

• 61532-80-7 1-benzyl-2-nitromethylene-hexahydro-pyrimidine 
• 109-76-2 Trimethylenediamine 
• 1350522-91-6 C₂₄H₂₅ClN₄O₃ 
• 1350522-74-5 10-benzyl-2-(2-methoxyphenyl)-2,3,8,9,10,11-hexahydro-1H-pyrazolo[4',3':3,4]pyrido[1,2-a][1,4]diazepine-1,5(7H)-dione hydrochloride 
• 1278416-40-2 10-benzyl-2-(2-chlorophenyl)-2,3,8, 9,10,11-hexahydro-1H-pyrazolo[4',3':3,4]pyrido[1,2-a][1,4]diazepine-1,5(7H)-dione 
• 1350522-73-4 10-benzyl-2-(2-chlorophenyl)-2,3,8,9,10,11-hexahydro-1H-pyrazolo[4',3':3,4]pyrido[1,2-a][1,4]diazepine-1,5(7H)-dione hydrochloride 
• 3436-51-9 2,7-bis-[3-(benzylamino)propyl]benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone 
• 1278416-72-0 methyl [(4Z)-4-(4-benzyl-1,4-diazepan-2-ylidene)-1-(2-chlorophenyl)-5-oxo-4,5-dihydro-1H-pyrazol-3-yl]acetate 
• 108992-03-6 1-benzyl-2-chloromethyl-1,4,5,6-tetrahydro-pyrimidine; hydrochloride 
• 77869-78-4 N-<2-(3-benzylhexahydropyrimidino)ethyl>propionanilide 
• 77869-66-0 N-<2-(3-benzylhexahydropyrimidino)ethyl>aniline 
• 77869-79-5 N-[2-(3-Benzyl-tetrahydro-pyrimidin-1-yl)-ethyl]-N-phenyl-propionamide; compound with oxalic acid 

Relevant articles and documents

Amines and polyamines from nitriles

-

A new kind of acetylcholine esterase inhibitors and its preparation method and application (by machine translation)

The present invention provides a novel acetyl choline esterase inhibitor and its preparation method and application, in particular, the invention discloses a formula A shown with double AChE binding site of substituted acridine compound, and its preparation method and as acetylcholinesterase inhibitors. The preparation of the novel compounds of this invention demonstrate good inhibit acetylcholine esterase role, can be used as a preparation for treating and preventing HAMER (AD) application value. (by machine translation)

Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases

N-alkylated polyamine analogues have potential as anticancer and antiparasitic drugs. However, their metabolism in the host has remained incompletely defined thus potentially limiting their utility. Here, we have studied the degradation of three different spermine analogues N,N′-bis-(3-ethylaminopropyl)butane-1,4-diamine (DESPM), N-(3-benzyl-aminopropyl)-N′-(3-ethylamino-propyl)butane-1,4-diamine (BnEtSPM) and N,N′-bis-(3-benzylaminopropyl)butane-1,4-diamine (DBSPM) and related mono-alkylated derivatives as substrates of recombinant human polyamine oxidase (APAO) and spermine oxidase (SMO). APAO and SMO metabolized DESPM to EtSPD [Km(APAO) = 10 μM, kcat(APAO) = 1.1 s -1 and Km(SMO) = 28 μM, kcat(SMO) = 0.8 s-1, respectively], metabolized BnEtSPM to EtSPD [Km(APAO) = 0.9 μM, kcat(APAO) = 1.1 s-1 and Km(SMO) = 51 μM, kcat(SMO) = 0.4 s-1, respectively], and metabolized DBSPM to BnSPD [Km(APAO) = 5.4 μM, k cat(APAO) = 2.0 s-1and Km(SMO) = 33 μM, kcat(SMO) = 0.3 s-1, respectively]. Interestingly, mono-alkylated spermine derivatives were metabolized by APAO and SMO to SPD [EtSPM Km(APAO) =16 μM, kcat(APAO) = 1.5 s -1; Km(SMO) = 25 μM, kcat(SMO) = 8.2 s -1; BnSPM Km(APAO) = 6.0 μM, kcat(APAO) = 2.8 s-1; Km(SMO) =19 μM, kcat(SMO) = 0.8 s-1, respectively]. Surprisingly, EtSPD [Km(APAO) = 37 μM, kcat(APAO) = 0.1 s-1; Km(SMO) =48 μM, kcat(SMO) = 0.05 s-1] and BnSPD [Km(APAO) = 2.5 μM, kcat(APAO) = 3.5 s-1; Km(SMO) =60 μM, kcat(SMO) = 0.54 s-1] were metabolized to SPD by both the oxidases. Furthermore, we studied the degradation of DESPM, BnEtSPM or DBSPM in the DU145 prostate carcinoma cell line. The same major metabolites EtSPD and/or BnSPD were detected both in the culture medium and intracellularly after 48 h of culture. Moreover, EtSPM and BnSPM were detected from cell samples. Present data shows that inducible SMO parallel with APAO could playanimportant roleinpolyamine based drug action, i.e. degradation of parent drug and its metabolites, having significant impact on efficiency of these drugs, and hence for the development of novel N-alkylated polyamine analogues. Springer-Verlag 2009.